Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Proton versus photon radiation therapy: A clinical review.

16/03/2023
/ Publications
/
Clinical Trial

This review summarized comparative clinical outcomes between proton and photon radiotherapy. 63 interventional comparative studies were presented in this...

Establishing cost-effective allocation of proton therapy for patients with mediastinal Hodgkin lymphoma

08/08/2021
/ Publications
/
Dosimetry
IMRT

A health-economic study by the Jacksonville group. This study utilized (1) patient-level dosimetric information for a cost-effectiveness analysis using a Markov...

Current Situation of Proton Therapy for Hodgkin Lymphoma: From Expectations to Evidence

08/07/2021
/ Publications
/
Secondary cancer

Consolidative radiation therapy (RT) is of prime importance for early-stage Hodgkin lymphoma (HL) management since it significantly increases progression-free...

Proton Therapy For Lymphomas: Current State Of The Art

01/10/2019
/ Publications

A review of latest development on lymphomas management with proton therapy, including details of proton physic properties, delivery techniques of passive...

Comparing second cancer risk for multiple radiotherapy modalities in survivors of Hodgkin lymphoma

10/04/2021
/ Publications
/
Secondary cancer
VMAT

Using Excess Absolute Risk (EAR) models, this study compared the risk of secondary cancer for Hodgkin lymphoma survivors after either IMRT or PBT radiation...

Clinical IMPT for Hodgkin lymphoma: which patients benefit the most?

01/01/2019
/ Publications
/
Pencil Beam Scanning - PBS

21 HL patients treated with deep inspiration breath-hold pencil-beam scanning (PBS) PT. Normal tissue radiation doses were calculated and compared to doses from...

Proton theraphy for adults with mediastinal lymphomas: The international lymphoma radiation oncology group (ILROG) guidelines.

08/08/2018
/ Publications

Radiation treatment techniques that increase the excess radiation dose to organs at risk (OARs) puts patients at risk of increased side effects, especially late...

Evidence-based Review on the Use of PT in Lymphoma from the PTCOG Lymphoma Subcommittee.

05/09/2017
/ Publications

In an effort to draw attention to the use of proton therapy in lymphoma, and as a resource for future consideration of proton therapy coverage for lymphoma by...

Proton Therapy For Lymphomas: Current State Of The Art

07/10/2019
/ Publications
/
Pencil Beam Scanning - PBS

A review of latest development on lymphomas management with proton therapy, including details of proton physic properties, delivery techniques of passive...

2-year relapse-free survival of 85% with no grade 3 toxicity

30/08/2016
/ Publications
/
Toxicity

A registry study of collective proton centres reported a 2-year relapse-free survival of 85% with no grade 3 toxicity occurred. Hodgkin lymphoma young survivors...